Evidence map›Paper›PMID 33982175›Full record

ArticleHerzschrittmachertherapie & Elektrophysiologie2021

[The wearable cardioverter defibrillator as diagnostic tool : Case report from remote monitoring daily practice].

Tobyson Pulickal, Thomas M Helms, Christian A Perings

Open access · greenAbstract readCase Reports
In one paragraph

Article in Herzschrittmachertherapie & Elektrophysiologie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Tobyson PulickalKatholisches Klinikum Lünen / Werne St.-Marien-Hospital Lünen, Medizinische Klinik 1, Lünen, Deutschland.
Thomas M HelmsDeutsche Stiftung für chronisch Kranke, Fürth, Deutschland. Thomas_Helms@t-online.de.
Christian A PeringsKatholisches Klinikum Lünen / Werne St.-Marien-Hospital Lünen, Medizinische Klinik 1, Lünen, Deutschland.
Katholisches Klinikum Lünen/Werne , St.-Marien-Hospital Lünen · DEDeutsche Stiftung für Chronisch Kranke · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedical care can point out new applications of already established therapeutics such as a wearable cardioverter-defibrillator (WCD) and improve the quality of care for chronically ill patients with heart failure through improved management of data derived from this device. The current case report describes the clinical course of a 71-year-old man, who was treated with a WCD in accordance with the current guidelines until a final decision was made about ICD implantation, after acute cardiac decompensation and lately diagnosed severe decrease of left ventricular function in the context of ischaemic cardiomyopathy. The data collected by the WCD were evaluated in a structured way via a telemedicine centre (TMC) and recurrence of the previously known paroxysmal atrial fibrillation (AF) was discovered. This made it possible to treat the paroxysmal AF, before cardiac decompensation happened again by adjusting the medication and early initiation of pulmonary vein isolation (PVI). This case exemplifies the usefulness of structured telemedical intervention, which makes it possible to meaningfully supplement established concepts of patient care, improve existing concepts and significantly improve patient care.

Indexed as

Death, Sudden, CardiacWearable Electronic DevicesAgedDefibrillatorsElectric CountershockElectrocardiographyHumansMaleHeart failurePrognosis improvementPulmonary vein isolationTelemedicineWearable defibrillator vest

Identifiers

PMID33982175
PMCPMC8114974
OpenAlexW3160800893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.